related documents
- Effect of torcetrapib combined with atorvastatin on HDL-C and LDL-C levels, particle size, and composition: A phase 2 dose-ranging clinical trial Conferences
- Mo-P4:279 Prevalence and predictors of subclinical atherosclerosis among asymptomatic low risk individuals in a multiethnic population Conferences
- Mo-P6:391 Identification of a chromosome 8P locus for coronary heart disease in the French Canadian founder population Conferences
- Th-W55:1 The portfolio diet: The role of vegetable protein and other dietary components in hypercholesterolemia Conferences
- Th-W55:7 Effect of a dietary portfolio of cholesterol lowering foods on blood pressure Conferences
- Th-W60:6 Tissue-specific sialidase deficiency protects against atherosclerosis in experimental animals Conferences
- The capacity of HDL to stimulate cholesterol efflux is maintained in subjects with and without low HDL-C treated with torcetrapib Conferences
- We-P14:433 Possible importance of colonic fermentation to potentiate the cholesterol lowering properties of soy but not of oat B-glucan Conferences
- We-W31:5 Homocysteine and folic acid levels and relation to carotid atherosclerosis in high-risk individuals Conferences
- We-W40:1 New anticoagulants for atherothrombosis Conferences